Difference between revisions of "Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study"
From Clinfowiki
(→Background) |
|||
Line 1: | Line 1: | ||
== Background == | == Background == | ||
− | The implementation of existing clinical guidelines for Chronic Kidney Disease (CKD) is inadequate. This article evaluates how guideline-based | + | The implementation of existing clinical guidelines for Chronic Kidney Disease (CKD) is inadequate. This article evaluates how guideline-based Clinical Decision Support System [[CDS|(CDSS)]] affects laboratory monitoring of patients with Stage 3-4 Chronic Kidney Disease, an attaining laboratory goals in those patients. <ref name="CKD"> Ennis, J., Gillen, D., Rubenstein, A., Worcester, E., Brecher, M. E., Asplin, J., & Coe, F. (2015). Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC nephrology, 16(1), 163. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/ </ref> |
== Methods == | == Methods == |
Revision as of 02:17, 22 October 2015
Background
The implementation of existing clinical guidelines for Chronic Kidney Disease (CKD) is inadequate. This article evaluates how guideline-based Clinical Decision Support System (CDSS) affects laboratory monitoring of patients with Stage 3-4 Chronic Kidney Disease, an attaining laboratory goals in those patients. [1]
Methods
Results
Conclusions
Appendix
- Lab measurement frequency and range targets used in the analysis. [2]
- Baseline patient characteristics. [3]
- Estimated odds ratio for ordering laboratory tests within guideline-recommended intervals: CDSS vs Controls. [4]
- Effect of CDSS on adherence to guideline testing intervals for eGFR. [5]
- Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). [6]
- Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). [7]
- Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). [8]
- Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. [9]
My Comments
References
- ↑ Ennis, J., Gillen, D., Rubenstein, A., Worcester, E., Brecher, M. E., Asplin, J., & Coe, F. (2015). Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC nephrology, 16(1), 163. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/
- ↑ Lab measurement frequency and range targets used in the analysis. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab1/
- ↑ Baseline patient characteristics http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab2/
- ↑ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab3/
- ↑ Effect of CDSS on adherence to guideline testing intervals for eGFR. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig1/
- ↑ Effect of CDSS on adherence to guideline testing intervals for phosphorus (a) and PTH (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig2/
- ↑ Effect of CDSS on adherence to guideline testing intervals for LDL-C (a) and Urine Panels (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig3/
- ↑ Effect of CDSS on achievement of guideline targets for LDL cholesterol (a) and 25-D (b). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/figure/Fig4/
- ↑ Estimated odds ratio for achieving guideline-recommended laboratory test targets: CDSS vs Controls. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608162/table/Tab4/